Tetra Radar · FDA Approvals · Decision date

bepirovirsen: FDA decision date

Gsk PLC (GSK) · October 2026

In Q1, the US FDA accepted for priority review a New Drug Application (NDA) for bepirovirsen and set 26 October 2026 as the decision goal date.

Source: 6-K of 29 April 2026

The date has passed; Tetra Radar has not recorded an approval.

Gsk PLC on Tetra Radar

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.